topic

1138 TGFβ-specific T cells recognize megakaryocyte progenitors in patients with myeloproliferative neoplasms
Thomas Lisle, Maria Perez Penco, Morten Orebo Holmström, Josephine Hallundbæk Ruders, Jacob Handlos Grauslund, Vibe Skov, Lasse Kjær, Hans Hasselbalch, Mads Andersen

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1252; DOI: 10.1136/jitc-2023-SITC2023.1138
1139 Efficacy of injectable antigen presenting nanoparticles (AIM INJ), in solid tumor models
Haiyun Liu, Duong Nguyen, Durgadas Cherukaraveedu, Adam Parks, Bryan Hahn, Daniel Dembrow, Sojung Kim, Jack Ragheb, Aniket Wadajkar, Mathias Oelke

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1253; DOI: 10.1136/jitc-2023-SITC2023.1139
1140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomas
Dennis J Montoya, Siqi Long, Kyra A Toomey, Varun Viswanath, Shuai Chen, Michael Babich, Tianhong Li

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1254; DOI: 10.1136/jitc-2023-SITC2023.1140
1141 Immunization with plasmid DNA versus messenger RNA encapsulated in lipid nanoparticles leads to differences in immunological outcomes
Jena Moseman, Hannah M Brinkman, William Murphy, Douglas McNeel

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1255; DOI: 10.1136/jitc-2023-SITC2023.1141
1142 mRNA LNP vaccination with the tumor-specific antigen EGFRvIII bolsters CAR T cell activity in vivo
Jesse L Rodriguez, Tyler E Papp, Logan Zhang, Kelly A Hicks, Hamideh Parhiz, Zev Binder, Donald O’Rourke

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1256; DOI: 10.1136/jitc-2023-SITC2023.1142
1143 cDC1 engagement induces Th1 differentiation and tumor regression in vivo
Seonhui Shim, Meng Sun, Yue Liu, Chirag Partel, Janani Sridar, Clint Remarcik, Qi Hao, Marc Creixell, Marcia Stickler, Maria Pokrovskii, Kenneth Finn, Jonathan Powell, Fiona Harding

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1257; DOI: 10.1136/jitc-2023-SITC2023.1143
1144 MHC II neoantigen vaccines improve antitumor immunity and response to immune checkpoint inhibitor in cold tumor
Xueru Song, Chun Lu, Tao Shi, Yuting Luo, Yue Wang, Wei Liu, Jia Wei

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1258; DOI: 10.1136/jitc-2023-SITC2023.1144
1145 A lymph node targeted AMP-peptide vaccine generates functional T cell immunity against mutant p53 and BRAF
Martin Steinbuck, Xavier Cabana-Puig, Erica Palmer, Mimi M Jung, Thomas Williams, Jeff Zhang, Christopher M Haqq, Peter DeMuth

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1259; DOI: 10.1136/jitc-2023-SITC2023.1145
1146 Self-assembly neoantigen peptides for personalized cancer vaccines
Yu Zhao, Andrew Wang

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1260-A1262; DOI: 10.1136/jitc-2023-SITC2023.1146
1147 mRNAs encoding an innate immune receptor enhance the immunogenicity of lipid nanoparticle vaccines
Dania Zhivaki, Emily Gosselin, Jonathan Chow, Debrup Sengupta, Anastasia Nikiforov, Holly Concepcion, Chisom Arinze, Caitlin Sullivan, Jonathan Kagan

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1263; DOI: 10.1136/jitc-2023-SITC2023.1147

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages